GENMAB - AbbVie køber Pharmacyclics
-
Konsolideringen indenfor kræftområdet forsætter i stor stil:
"Drugmaker AbbVie Inc (ABBV.N) said it will buy Pharmacyclics Inc (PCYC.O), the maker of blockbuster cancer drug Imbruvica, for about $21 billion to broaden its oncology drugs pipeline.
Related StoriesThe deal gives AbbVie access to Pharmacyclics' cancer drugs portfolio, lessening the Chicago-based company's dependence on its rheumatoid arthritis drug Humira that accounts for most of its sales".
http://finance.yahoo.com/news/abbvie-buy-cancer-drug-maker-050113563.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind